Skip to content
Life Sciences Series A Founded 2008

Photanol

Provider of technology for light-powered bio-production of chemicals. The company is developing a platform technology that uses genetically modified cyanobacteria to directly convert carbon dioxide into specific high-value chemicals. It used for different plastics, the ingredients for personal care products and detergents. The company was founded in 2008 and headquartered in Amsterdam, Netherlands. It has raised…

📍 Amsterdam, Netherlands · Genomics,

Funding snapshot

Last roundSeries A
Amount$56K
Date30 November 2021
Total raised$9M
Team size13

About

Provider of technology for light-powered bio-production of chemicals. The company is developing a platform technology that uses genetically modified cyanobacteria to directly convert carbon dioxide into specific high-value chemicals. It used for different plastics, the ingredients for personal care products and detergents. The company was founded in 2008 and headquartered in Amsterdam, Netherlands. It has raised $9.3M in series a funding, with backing from EIC Fund, Europa, Icos Capital, Investment Fund Groningen, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Life Sciences Platforms and Tools space. Its offerings span Genomics - Applied Genomics - Microbial Genomics.

Business model

Genomics > Applied Genomics > Microbial Genomics,

Life Sciences Platforms and Tools > Research Services > Diversified

Institutional investors

EIC Fund Europa Icos Capital Investment Fund Groningen UvA Ventures Holding

Latest coverage

No articles yet.

Raising like Photanol?

Analyze your pitch deck before your next raise.

Analyze My Deck →